CMS finalizes requirement for hospitals to report MA plan rates
In the FY21 IPPS final rule, CMS expanded controversial negotiated-price reporting requirements.
HFMA provides insight into 3 key areas of CMS’s 2021 IPPS final rule
HFMA's Chad Mulvany offers insight on key areas of the Inpatient Prospective Payment Service final rule, including market-based MS-DRG weights, Uncompensated Care DSH and Medicare bad debt requirements.
CMS finalizes requirement for hospitals to report MA plan rates
Critical access hospitals will avoid Medicare cuts stemming from Paycheck Protection Program loans, Verma says
CMS does not intend for PPP loans to factor into Medicare payments to rural providers, the agency’s administrator recently clarified.
Create more accurate cost reports faster with Easy Work Papers by BESLER
A healthcare technology company talks about how its Easy Work Papers solution improves cost report accuracy and consistency, helping hospitals receive optimal revenue while maintaining compliance.
Hospitals worry latest Medicare transparency effort will increase costs
Hospitals have told CMS a proposed expansion of coming transparency requirements would increase their costs and costs of care overall.
HHS releases $4 billion more in COVID-19 assistance for hospitals
HHS recently released $4 billion in new coronavirus response assistance for hospitals based on their location, revenues and patient base.
Possible compromise in hospital price disclosure fight
While the Trump administration prevailed in the first round of the lawsuit challenging its price transparency policy, the American Hospital Association has indicated it will appeal the ruling.
New hospital price transparency requirements included in IPPS proposed rule
CMS wants hospitals to start reporting median health plan payment rates and may use the information to help determine Medicare rate changes.
Hospital price study draws pushback
The dramatic conclusion of new research that hospitals prices are more than 200 percent of Medicare rates is raising questions among industry analysts.